Can’t find a document? Request Information

PE-T1448 : TUMI Genomics: Next Generation Sequencing (NGS) Diagnosis for COVID-19

Project Status: Implementation

The solution proposed in this grant will increase the diagnostic capacity in Peru for SARS-CoV-2 and introduce a dramatically more sensitive and precise test than current tests (see additional information). Therefore, the immediate beneficiaries of our solution would be the Peruvian population, as well as the public health entities that are currently dealing with an accumulation of diagnostic tests. The world population will also benefit from our solution, as the data we collect in Peru can be used to track the evolution and movement of SARS-CoV-2 allowing effective containment of the pandemic. Long-term beneficiaries include the international community of drug researchers and developers who could use the viral genomic data collected by Tumi Genomics to reveal the molecular epidemiology and evolution of the SARS-CoV-2 virus and guide effective treatment.

Project Detail

Project Number
PE-T1448
Approval date
June 18, 2020
Project Country
Peru
Project Sector
HEALTH
Project Subsector
HEALTH SERVICES
Project Type
Technical Cooperation
Environmental and social impact category
C
Project Status
Implementation
Operation Number
ATN/ME-18053-PE

Financial Information

Project Number
PE-T1448
Project Status
Implementation

IDB Financing

Financing type
TCN
Fund
Multilateral Investment Fund II (MIF) -
Reporting currency
USD - United States Dollar
Reporting date
Oct/15/2021

Roles & Responsibilities

Contract signature date
Aug/03/2020

Project Information

Total Cost
USD 225,000
Country counterpart financing
USD 75,000
Amount
USD 150,000

Approved

Title
Type
Project Number
Date Published
Donors Memorandum
PE-T1448
July 13, 2021